LOS ANGELES, Jan. 17, 2018 (GLOBE NEWSWIRE) — Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and … Read More
The post Vitality Biopharma Submits Orphan Drug Designation Request to FDA for Flagship THC Prodrug … appeared first on Dagga Magazine.